LILLY ENDOWMENT INC 4

Accession 0000316011-25-000092

CIK 0000059478other

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 4:00 PM ET

Size

55.8 KB

Accession

0000316011-25-000092

Insider Transaction Report

Form 4

Period: 2025-11-25

ELI LILLY & CoLLY

LILLY ENDOWMENT INC

10% Owner

Transactions

Sale
Common Stock
2025-11-25$1073.73/sh−2,481$2,663,937→ 92,357,190 total
Sale
Common Stock
2025-11-25$1076.00/sh−882$949,029→ 92,356,308 total
Sale
Common Stock
2025-11-25$1077.99/sh−800$862,390→ 92,355,508 total
Sale
Common Stock
2025-11-25$1079.37/sh−1,260$1,360,002→ 92,354,248 total
Sale
Common Stock
2025-11-25$1080.73/sh−651$703,557→ 92,353,597 total
Sale
Common Stock
2025-11-25$1081.90/sh−1,606$1,737,531→ 92,351,991 total
Sale
Common Stock
2025-11-25$1082.93/sh−160$173,269→ 92,351,831 total
Sale
Common Stock
2025-11-25$1084.70/sh−3,069$3,328,950→ 92,348,762 total
Sale
Common Stock
2025-11-25$1086.07/sh−5,604$6,086,331→ 92,343,158 total
Sale
Common Stock
2025-11-25$1086.94/sh−6,508$7,073,812→ 92,336,650 total
Sale
Common Stock
2025-11-25$1087.96/sh−5,589$6,080,636→ 92,331,061 total
Sale
Common Stock
2025-11-25$1088.91/sh−5,284$5,753,785→ 92,325,777 total
Sale
Common Stock
2025-11-25$1089.85/sh−1,907$2,078,352→ 92,323,870 total
Sale
Common Stock
2025-11-25$1091.12/sh−5,927$6,467,045→ 92,317,943 total
Sale
Common Stock
2025-11-25$1092.06/sh−18,254$19,934,427→ 92,299,689 total
Sale
Common Stock
2025-11-25$1093.16/sh−9,050$9,893,134→ 92,290,639 total
Sale
Common Stock
2025-11-25$1094.03/sh−6,246$6,833,286→ 92,284,393 total
Sale
Common Stock
2025-11-25$1094.79/sh−2,083$2,280,456→ 92,282,310 total
Sale
Common Stock
2025-11-25$1096.33/sh−1,061$1,163,205→ 92,281,249 total
Sale
Common Stock
2025-11-25$1097.44/sh−4,198$4,607,066→ 92,277,051 total
Sale
Common Stock
2025-11-25$1098.32/sh−4,639$5,095,083→ 92,272,412 total
Sale
Common Stock
2025-11-25$1099.48/sh−6,545$7,196,129→ 92,265,867 total
Sale
Common Stock
2025-11-25$1100.34/sh−8,527$9,382,565→ 92,257,340 total
Sale
Common Stock
2025-11-25$1101.45/sh−11,854$13,056,576→ 92,245,486 total
Sale
Common Stock
2025-11-25$1102.35/sh−7,456$8,219,092→ 92,238,030 total
Sale
Common Stock
2025-11-25$1103.58/sh−6,274$6,923,836→ 92,231,756 total
Sale
Common Stock
2025-11-25$1104.41/sh−5,196$5,738,520→ 92,226,560 total
Sale
Common Stock
2025-11-25$1105.32/sh−2,494$2,756,668→ 92,224,066 total
Sale
Common Stock
2025-11-25$1106.57/sh−3,662$4,052,270→ 92,220,404 total
Sale
Common Stock
2025-11-25$1107.48/sh−7,794$8,631,699→ 92,212,610 total

Footnotes (30)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,073.78 to $1,074.77, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), (23), (24), (25), (26), (27), (28), (29), and (30) to this Form 4.
[F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,086.50 to $1,087.49, inclusive.
[F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,087.50 to $1,088.48, inclusive.
[F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,088.50 to $1,089.47, inclusive.
[F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,089.51 to $1,090.46, inclusive.
[F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,090.57 to $1,091.55, inclusive.
[F15]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,091.58 to $1,092.57, inclusive.
[F16]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,092.58 to $1,093.57, inclusive.
[F17]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,093.58 to $1,094.53, inclusive.
[F18]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,094.65 to $1,095.32, inclusive.
[F19]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,095.86 to $1,096.70, inclusive.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,075.50 to $1,076.47, inclusive.
[F20]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,096.87 to $1,097.86, inclusive.
[F21]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,097.87 to $1,098.84, inclusive.
[F22]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,098.87 to $1,099.85, inclusive.
[F23]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,099.87 to $1,100.83, inclusive.
[F24]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,100.87 to $1,101.86, inclusive.
[F25]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,101.87 to $1,102.86, inclusive.
[F26]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,102.97 to $1,103.96, inclusive.
[F27]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,103.97 to $1,104.96, inclusive.
[F28]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,104.97 to $1,105.96, inclusive.
[F29]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,105.99 to $1,106.98, inclusive.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,077.64 to $1,078.38, inclusive.
[F30]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,107.00 to $1,107.95, inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,078.84 to $1,079.52, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,080.10 to $1,081.00, inclusive.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,081.36 to $1,082.25, inclusive.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,082.82 to $1,083.00, inclusive.
[F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,084.50 to $1,085.45, inclusive.
[F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,085.50 to $1,086.45, inclusive.

Documents

1 file

4
form4-11262025_041101.xmlPrimary

Issuer

ELI LILLY & Co

CIK 0000059478

→

Entity typeother

IncorporatedIN

Related Parties

filerCIK 0000316011

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 4:00 PM ET
Size: 55.8 KB

View on SEC.gov